TWD
BNTC icon

True Wealth Design’s Benitec Biopharma BNTC Stock Holding History

True Wealth Design’s Portfolio BNTC Stock Details BNTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$180 Sell
18
-5
-22% -$61 ﹤0.01% 2363
2026
Q2 		$308 Buy
23
+22
+2,200% +$261 ﹤0.01% 2345
2026
Q1 		$11 Buy
+1
New +$12 ﹤0.01% 2663

Other funds holding BNTC

GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

True Wealth Design's BNTC Position: Q3 2026 in Review

True Wealth Design reduced its Benitec Biopharma (BNTC) stake by 22% in Q3 2026, selling an estimated $61 and leaving 18 shares worth $180. The position accounts for ﹤0.01% of the portfolio, ranked #2363.

True Wealth Design first reported a position in BNTC in Q1 2026 and has held it in 3 quarters since. The position peaked at $308 in Q2 2026. 4 funds tracked by Wall St. Rank hold BNTC as of Q3 2026.

  • True Wealth Design held 18 shares of Benitec Biopharma worth $180 as of Q3 2026.
  • True Wealth Design sold 5 Benitec Biopharma shares in Q3 2026, an estimated $61.
  • Benitec Biopharma made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #2363 holding.
  • True Wealth Design first reported a position in Benitec Biopharma in Q1 2026 and has held it in 3 quarters since.
  • True Wealth Design's Benitec Biopharma position peaked at $308 in Q2 2026.
  • 4 funds tracked by Wall St. Rank held Benitec Biopharma as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.